Karakasis, P.; Fragakis, N.; Patoulias, D.; Theofilis, P.; Sagris, M.; Koufakis, T.; Vlachakis, P.K.; Rangraze, I.R.; El Tanani, M.; Tsioufis, K.;
et al. The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure? Biomedicines 2024, 12, 2112.
https://doi.org/10.3390/biomedicines12092112
AMA Style
Karakasis P, Fragakis N, Patoulias D, Theofilis P, Sagris M, Koufakis T, Vlachakis PK, Rangraze IR, El Tanani M, Tsioufis K,
et al. The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure? Biomedicines. 2024; 12(9):2112.
https://doi.org/10.3390/biomedicines12092112
Chicago/Turabian Style
Karakasis, Paschalis, Nikolaos Fragakis, Dimitrios Patoulias, Panagiotis Theofilis, Marios Sagris, Theocharis Koufakis, Panayotis K. Vlachakis, Imran Rashid Rangraze, Mohamed El Tanani, Konstantinos Tsioufis,
and et al. 2024. "The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure?" Biomedicines 12, no. 9: 2112.
https://doi.org/10.3390/biomedicines12092112
APA Style
Karakasis, P., Fragakis, N., Patoulias, D., Theofilis, P., Sagris, M., Koufakis, T., Vlachakis, P. K., Rangraze, I. R., El Tanani, M., Tsioufis, K., & Rizzo, M.
(2024). The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure? Biomedicines, 12(9), 2112.
https://doi.org/10.3390/biomedicines12092112
